Perturbations in gut microbiota composition in schizophrenia.

Area of Science:

• Microbiology
• Neuroscience
• Psychiatry

Background:

• Schizophrenia is a complex psychiatric disorder with an unclear cause.
• The gut-brain axis highlights the connection between gut microbes and the central nervous system.
• Research into the gut microbiota's role in schizophrenia is needed.

Purpose of the Study:

• To investigate the relationship between gut microbial composition and function in patients with schizophrenia.
• To compare the gut microbiota of individuals with schizophrenia to that of healthy controls.

Main Methods:

• 16S rRNA gene sequencing and whole-genome shotgun metagenomic sequencing were performed.
• Microbial diversity, composition, and function were analyzed in 29 schizophrenia patients and 30 healthy controls.
• Statistical analyses were used to identify differences between the groups.

Main Results:

• Patients with schizophrenia exhibited higher abundances of Clostridium and Megasphaera compared to controls.
• Functional analysis indicated associations between sphingolipid, phosphonates and phosphinates, and glutamine metabolism with schizophrenia.
• Significant differences in gut microbial profiles were observed between schizophrenia patients and healthy individuals.

Conclusions:

• The gut microbiota composition and function are altered in patients with schizophrenia.
• Specific bacterial taxa and metabolic pathways in the gut may be implicated in the pathophysiology of schizophrenia.
• These findings offer insights into potential gut microbiota-targeted interventions for schizophrenia.